5 results match your criteria: "University Hospital and Centre of Coimbra[Affiliation]"
Reply from author: Atrial fibrillation and functional tricuspid or mitral regurgitation: Which comes first, the egg or the chicken?
JTCVS Open
March 2022
Faculty of Medicine, Cardiothoracic Surgery Department, University Hospital and Centre of Coimbra, University of Coimbra, Coimbra, Portugal.
Transapical off-pump mitral valve repair with NeoChord implantation: Is less better?
Rev Port Cardiol (Engl Ed)
December 2021
University Hospital and Centre of Coimbra, Cardiothoracic Surgery Department, Faculty of Medicine, University of Coimbra, Portugal. Electronic address:
Commentary: Mild tricuspid regurgitation in rheumatic mitral surgery: To do, or not do, that is the question.
J Thorac Cardiovasc Surg
April 2023
Cardiothoracic Surgery Department, University Hospital and Centre of Coimbra; Faculty of Medicine, University of Coimbra, Portugal. Electronic address:
Vascular activity of infusion and fractions of Cymbopogon citratus (DC) Stapf. in human arteries.
J Ethnopharmacol
August 2020
Laboratory of Pharmacology and Pharmaceutical Care, Faculty of Pharmacy of University of Coimbra, University of Coimbra, Portugal; Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal; CIBB Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Portugal. Electronic address:
Ethnopharmacological Relevance: Cymbopogon citratus (DC.) Stapf has been traditionally used mainly for inflammatory diseases and hypertension. However, the mechanisms underlying its vascular activity remain to be fully characterized and the fractions responsible for its cardiovascular activity are still unknown.
View Article and Find Full Text PDFMitral valve repair for degenerative mitral valve disease: surgical approach, patient selection and long-term outcomes.
Heart
November 2017
Cardiothoracic Surgery, University Hospital and Centre of Coimbra, Coimbra, Portugal.
Mitral valve repair (MVRepair) has become the procedure of choice to correct severe degenerative mitral regurgitation (MR), due to its documented superiority to valve replacement regarding long-term survival, freedom from valve-related adverse events and preservation of left ventricular (LV) function. The refinement of MVRepair techniques has rendered almost all valves (more than 95%) amenable to repair with a 15-year freedom from reoperation of 90%. The concept of 'centres of excellence for MVRepair' has emerged, encouraging referring doctors to select the most experienced institutions or individual surgeons to deal with the most complex cases, based on repair volume, appropriate peri-procedural imaging and data regarding expected outcomes (repair, mortality and durability of repair).
View Article and Find Full Text PDF